Bayer, Curadev Enter ‘STING’ Pact Exploring Inflammatory Disease
Duo Using Curadev’s Stimulator Of Interferon Genes Antagonist Platform
• By Sten Stovall
The STING agonist program aims to kick-start innate immune responses in tumors • Source: Shutterstock 
